From treatment to prevention of bleeds: what more evidence do we need? - Wikidata - awgldk - TriplyDB

From treatment to prevention of bleeds: what more evidence do we need?

From treatment to prevention of bleeds: what more evidence do we need?

http://www.wikidata.org/entity/Q45868153

about

From treatment to prevention of bleeds: what more evidence do we need?

http://www.wikidata.org/entity/Q45868153

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

From treatment to prevention of bleeds: what more evidence do we need?

@en

From treatment to prevention of bleeds: what more evidence do we need?

@nl

type

label

From treatment to prevention of bleeds: what more evidence do we need?

@en

From treatment to prevention of bleeds: what more evidence do we need?

@nl

prefLabel

From treatment to prevention of bleeds: what more evidence do we need?

@en

From treatment to prevention of bleeds: what more evidence do we need?

@nl

P1433

Q45868153-22CE242F-A5FC-4C73-B6BD-6E74C12AF329

P1476

Q45868153-40D767C9-9B01-48AA-8182-B5ECDC809447

P2093

Q45868153-1898C879-8DE7-43B4-8CF0-7922CBB645B3

P2860

Q45868153-0A128D34-8B1A-44F4-806A-DF60CBCB54B7

Q45868153-12F557B9-6CB5-4FD4-9AAA-4D4C92FAAE42

Q45868153-162E89A7-46CA-460A-A64C-336A3A3C1D36

Q45868153-19BC75A8-1D89-4E7F-9CFC-111FD9C30F07

Q45868153-2D3C67A7-7F9E-4CDB-8069-E02ACE0DD77D

Q45868153-2FD991A6-EDF8-44FF-BCF6-1D32B316D80F

Q45868153-34492CFC-D3F9-48D5-B5D2-E1F4D6A9E15A

Q45868153-4D226DDB-06F2-47D2-B914-7268AC7A63B3

Q45868153-4F905726-7295-4B11-9D95-84CC0138D9B9

Q45868153-53E2D7EA-0E10-4B3F-A7A9-E083C291F37B

P304

Q45868153-357A670C-9621-4A0B-9CA3-1E1E604F464A

P31

Q45868153-5548A502-D0DD-4B93-AC0C-A5416C4A878E

P356

Q45868153-793B461C-0030-4A11-9604-B48E2339D9F9

P433

Q45868153-5CCE9D4D-01CE-4969-A6BD-F0DF010B7215

P478

Q45868153-F8FD6C0E-1550-4A55-AB60-8394CE748827

P50

Q45868153-1292373B-D8E3-41BD-958A-2BE465746415

P577

Q45868153-82DFFFEB-E97E-401C-A5D4-8D24D67E4B0F

P698

Q45868153-4AD88621-20B5-411E-9FB9-F45FDF2218B5

P356

P1433

P1476

From treatment to prevention of bleeds: what more evidence do we need?

@en

P2093

H M van den Berg

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Prophylaxis for severe hemophilia: experience from Europe and the United States.

Pathogenesis of haemophilic arthropathy.

Men with severe hemophilia in the United States: birth cohort analysis of a large national database

Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s

Episodic replacement of clotting factor concentrates does not prevent bleeding or musculoskeletal damage - the MUSFIH study.

Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.

Cell phones and landlines: the impact of gene therapy on the cost and availability of treatment for hemophilia.

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades.

P304

494-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.13256

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

H M van den Berg

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28544023

http://www.w3.org/2001/XMLSchema#string